IMARC Group, a leading market research company, has recently releases report titled, “Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global alopecia treatment market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights
How big is the alopecia treatment market?
Report Attributes | Details |
Market Size in 2022 | US$ 3.1 Billion |
Market Forecast in 2028 | US$ 4.1 Billion |
Growth rate (2023 to 2028) | CAGR of 4.75% |
Base Year of the Analysis | 2022 |
Forecast Period | 2023-2028 |
What is alopecia treatment?
Alopecia is a medical condition that causes hair loss on the scalp and other parts of the body. Some common types of alopecia include androgenetic, areata, totalis, universalis, and telogen effluvium and can affect people of all ages, genders, and ethnicities. It can be treated with different solutions, such as topical and oral medications, injections, and hair transplant procedures. These treatments work by blocking the attack of the immune system on the affected area and stimulating hair regrowth. At present, alopecia can be treated by phototherapy or low light laser therapy (LLLT) as it is a less invasive, safer, and more tolerable alternative to traditional treatments. Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/alopecia-treatment-market/requestsampleWhat are the growth prospects and trends in the alopecia treatment industry?
The global alopecia treatment market is primarily driven by the rising awareness among people regarding available treatments for alopecia. Moreover, the increasing prevalence of hair loss and baldness due to sedentary lifestyles and hectic routines of working professionals has augmented the demand for effective alopecia treatment. Additionally, numerous technological advancements and the introduction of novel, non-invasive treatment methods have catalyzed market growth. Furthermore, the rising investments by private and public agencies to upgrade the healthcare infrastructure is contributing to the market growth. Other factors, including extensive research and development (R&D) activities, increasing geriatric population, and continual development of healthcare facilities, are also anticipated to drive the market further.What is included in market segmentation?
The report has segmented the market into the following categories: Breakup by Drug Type:- Minoxidil
- Finasteride
- Others
- Androgenic Alopecia
- Alopecia Areata
- Alopecia Totalis
- Others
- Male
- Female
- Oral
- Topical
- Injectable
- Hospitals
- Retail Pharmacies
- Online Pharmacies
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:- Aclaris Therapeutics Inc.
- Cellmid Limited
- Cipla Limited
- Reddy’s Laboratories Ltd.
- GlaxoSmithKline plc
- HCell Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- Taisho Pharmaceutical Holdings Co Ltd
- Teva Pharmaceutical Industries Ltd.